General Atlantic LLC
- SEC CIK
- 0001017645
- Latest filing
- Aug 14, 2026
Holdings in Q4 2024
Holdings as of Dec 31, 2024, filed Feb 7, 2025. Long positions only; changes compare share counts with Q3 2024.
- Positions
- 16
- −2 vs. Q3 2024
- Portfolio value
- $2.81B
- −$708.2M (−20.1%) vs. Q3 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| DLOdLocal Ltd | CLASS A COM | 63,906,695 | $719.6M | 25.6% | 00.0% | Unchanged | History |
| ALHCAlignment Healthcare, Inc. | COM | 60,993,323 | $686.2M | 24.4% | 00.0% | Unchanged | History |
| ALKTAlkami Technology, Inc. | Stock | 9,645,318 | $353.8M | 12.6% | −5,875,000−37.9% | Reduced | History |
| XPXP Inc. | CL A | 29,617,733 | $351.0M | 12.5% | 00.0% | Unchanged | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 9,681,818 | $162.2M | 5.8% | 00.0% | Unchanged | History |
| AKROAkero Therapeutics, Inc. | COM | 5,233,989 | $145.6M | 5.2% | 00.0% | Unchanged | History |
| PHVSPharvaris N.V. | COM | 7,531,252 | $144.4M | 5.1% | 00.0% | Unchanged | History |
| EWCZEuropean Wax Center, Inc. | CLASS A COM | 13,110,492 | $87.4M | 3.1% | 00.0% | Unchanged | History |
| RPRXRoyalty Pharma plc | SHS CLASS A | 1,500,000 | $38.3M | 1.4% | 00.0% | Unchanged | History |
| IMCRImmunocore Holdings plc | ADS | 1,261,684 | $37.2M | 1.3% | 00.0% | Unchanged | History |
| THRDThird Harmonic Bio, Inc. | COM | 3,372,323 | $34.7M | 1.2% | +413,561+14.0% | Added | History |
| RSKDRiskified Ltd. | SHS CL A | 5,324,998 | $25.2M | 0.9% | 00.0% | Unchanged | History |
| SLRNACELYRIN, Inc. | COM | 2,695,327 | $8.46M | 0.3% | −194,341−6.7% | Reduced | History |
| ADAGAdagene Inc. | ADS | 3,825,952 | $7.61M | 0.3% | +3,561,952+1,349.2% | Added | History |
| LOGCContextLogic Holdings Inc. | CL A NEW | 609,616 | $4.29M | 0.2% | 00.0% | Unchanged | History |
| GROVGrove Collaborative Holdings, Inc. | COM CL A | 2,474,859 | $3.44M | 0.1% | +1,538,839+164.4% | Added | History |
Sold out since Q3 2024 (2)
Positions held at the end of Q3 2024 that are gone from this filing.